Pulmonx (LUNG) Current Assets (2019 - 2025)

Pulmonx (LUNG) has 7 years of Current Assets data on file, last reported at $101.7 million in Q4 2025.

• Quarterly Current Assets fell 25.37% year-over-year to $101.7 million in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $101.7 million (down 25.37% YoY) and the FY2025 annual result came in at $101.7 million, down 25.37% from the prior year.
• Current Assets declined to $101.7 million in Q4 2025 per LUNG's latest filing, from $111.2 million in the prior quarter.
• Across five years, Current Assets topped out at $239.3 million in Q1 2021 and bottomed at $101.7 million in Q4 2025.
• The 5-year median for Current Assets is $157.4 million (2023), against an average of $166.3 million.
• The widest annual swing landed in 2021, when Current Assets soared 309.27%; it then slipped 25.37% in 2025.
• Tracing LUNG's Current Assets over 5 years: stood at $208.0 million in 2021, then declined by 18.77% to $169.0 million in 2022, then retreated by 10.97% to $150.4 million in 2023, then decreased by 9.42% to $136.2 million in 2024, then slipped by 25.37% to $101.7 million in 2025.
• Per Business Quant, the three latest LUNG Current Assets figures stand at $101.7 million (Q4 2025), $111.2 million (Q3 2025), and $120.0 million (Q2 2025).

Peer Comparison